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Abstract
Background and aims. Laparoscopic distal pancreatectomy (LDP) is a safe alternative to conventional open distal
pancreatectomy, with advantages that include smaller incisions, less pain, and shorter postoperative recovery. Despite these
apparent advantages, however, uptake of the procedure has been slow, with only a handful of series published. Material and
methods. All LDPs performed in Brisbane, Australia, over a 10-year period (May 1996 to June 2006) were retrospectively
reviewed. Results. Forty-six consecutive LDPs were performed. A variety of lesions were resected, including nine cancers.
Twelve patients were converted for oncological (6) or technical reasons (6). The spleen was retained in 14/29 patients,
either by main splenic vessel preservation (9) or solely supported by the short gastric vessels (5), resulting in inferior pole
infarction in 2 patients. Overall morbidity was 39%, including 15% pancreatic fistula. All fistulas resolved after a median of
6 weeks without re-operation. A non-significant trend toward fewer fistulas with stapled rather than sutured stump closure
was observed (13% vs 19%; p0.43). Median operative duration and hospital stay were 157 min and 7 days, respectively.
There was no mortality. Conclusion. LDP is a safe alternative to conventional resection for a wide range of lesions. As with
open resection, pancreatic fistula is the dominant morbidity, but is generally indolent. While spleen preservation is often
possible, care must be taken to avoid infarction of the inferior pole if the Warshaw technique is utilized.
Introduction
Laparoscopic resection of the pancreas remains
uncommon despite the widespread use of minimally
invasive surgery for other abdominal pathologies.
While the current evidence does not support laparo-
scopic pancreatico-duodenectomy, distal pancrea-
tectomy may well be suited to the laparoscopic
approach, because no anastomosis is required and
the size of incisions can be greatly reduced compared
to the conventional open approach. The published
literature concerning laparoscopic distal pancreatect-
omy (LDP) indicates the usual advantages of mini-
mal access surgery, including reduced postoperative
pain, faster recovery, and fewer wound-related pro-
blems.
Some of the main concerns about LDP include
questions about oncological adequacy, if the resec-
ted lesion proves to be malignant, and a perception of
a higher rate of pancreatic fistula. Clearly, large
comparative trials, ideally prospective and rando-
mized, help clarify these concerns; however, it is
surprising how few cases have been reported in the
world literature, the majority being in the form of
isolated case reports or small retrospective series with
fewer than 10 patients. This article reports on the
results of 46 patients and, to our knowledge, one of
the largest experiences by a single group of surgeons
to date. It is intended that these data contribute to the
published experience and begin specifically to address
some of the controversies including indications,
optimal pancreatic stump management, as well as
issues surrounding splenic preservation.
Methods
A detailed retrospective review was conducted of all
LDPs performed by a group of seven surgeons at five
related institutions in and around Brisbane (Queens-
land, Australia) between 1996 and 2006.
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The technique of LDP used was similar to that first
published by both Gagner [1] and Cuscheri in 1996
[2]. This involved exposure of the pancreatic neck,
body, and tail by division of the gastro-colic omentum
and mobilization of the splenic flexure. Using a
medial to lateral approach, the pancreatic neck was
transected by either harmonic scalpel or endoGIA
452.5 mm linear stapler and the distal pancreas
freed toward the spleen. A variety of techniques was
used to address the pancreatic stump, including
staples alone, augmented by fibrin sealant, sutures,
or omental patch, or sutured closure if transection was
carried out using ultrasonic shears. If splenectomy
was performed, the splenic artery and vein were
divided level with the pancreatic neck by endoGIA
452.5 mm, allowing the spleen to be taken en bloc
with the pancreas. In spleen preserving LDP, splenic
vessels were either preserved with ligation of pancrea-
tic side branches by clips and/or harmonic scalpel, or
resected with the distal pancreas using endoGIA,
relying on the short gastric vessels alone to maintain
splenic perfusion as described by Warshaw [3]. Plastic
specimen retrieval bags and a 19Fr closed suction
silicon drain were used routinely. The drain, which
was positioned near the pancreatic stump, was
removed by the third postoperative day if the lipase
content was less than 1000 IU.
All patients were given preoperative polyvalent
pneumococcal, meningococcal, and Haemophilus
influenzae vaccines. Routine anti-thromboembolic
measures, including intraoperative pneumatic calf
compressors and postoperative subcutaneous heparin,
were administered. Somatostatin analogs were not
routinely used.
Pancreatic fistula was defined as any persistent
lipase-rich drainage beyond the 6th postoperative
day, or the radiological insertion of a percutaneous
drain into a lipase-rich peri-pancreatic collection.
Results
Forty-six consecutive LDPs were performed. Patients
had a mean age of 59.8 years (range 2583 years) and
54% were female. A variety of pancreatic lesions was
resected (Table I).
The median duration of surgery was 139 min
(mean 157 min, range 90278), with median esti-
mated blood loss of 200 ml (mean 340 ml, range 30
2000 ml). Median length of hospital stay was 7 days
(mean 13.5 days, range 3100).
Conversion to open surgery was performed in a
total of 12 patients (26%) (Table II). The need to
convert was spread fairly evenly across the 10-year
period and was related to the pathology encountered
rather than as a consequence of the learning curve. In
six patients, a malignant appearance was discovered
when the lessor sac was opened, and all of these
patients were converted to ensure adequate margins
and lymphadenectomy. In the remaining six patients,
conversion was performed to deal more safely with
dense adhesions from previous surgery (3), splenic
vein bleeding (1), and a very bulky lesion (2).
A total of 13 patients had malignant tumors. This
became apparent early in the dissection in the 6 cases
discussed above and these were converted. The other
7 cases (5 ductal adenocarcinomas, 1 mucinous
cystadenocarcinoma, and 1 lymphoma) were com-
pleted laparoscopically, with the malignant nature of
the lesion not revealed until histopathological analysis.
Clear surgical margins were obtained in all 7 patients.
A variety of techniques addressing the pancreatic
stump were used according to individual surgeon
preference (Table III). Division of the pancreatic
neck by linear stapler was preferred by most surgeons.
Fibrin sealant was also frequently applied to the
stump in the latter part of the series, after this product
became available, reflecting a belief that this might
lower the rate of pancreatic fistula. One surgeon also
routinely added an omental patch after stapled
transection.
The overall incidence of pancreatic fistula was 15%
(7 patients), 4 in the stapled group (13%) and 3 in
Table I. Final pathology diagnoses (n46).
Pathology No.
Serous cystadenoma 10
Ductal adenocarcinoma 9
Mucinous cystadenoma 6
MEN1 3
Insulinoma 2
Non-functioning adenoma 2
Lymphoma 2
IPMN 2
Mucinous cystadenocarcinoma 1
Metastatic lung cancer 1
PanIN 1
Pseudopapillary tumor 1
Gastrinoma 1
Pseudocyst 1
Inflammatory pseudotumor 1
Hemangioma 1
Dermoid 1
Retention cyst 1
Table II. Conversion to open distal pancreatectomy; 12 cases
(26%).
Reason No.
Oncological
(50%)
Malignant appearance at initial laparoscopy 2
Concern regarding malignancy during dis-
section
3
Contiguous involvement of adjacent organs 1
Technical
(50%)
Adhesions from previous surgery 2
Massive size of lesion 2
Bleeding 1
Extraperitoneal insufflation 1
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whom the pancreas had been divided by ultrasonic
shears then oversewn (19%). This difference did not
reach statistical significance (p0.43). The addition
of augmented measures, including the use of fibrin
sealant to either a stapled or sutured pancreatic
stump, did not appear to make any difference to the
fistula rate.
Splenic preservation performed in 14 patients was
not considered in 10 patients with lesions very close to
the splenic hilum, in 6 patients converted because of
malignancy, and in 1 patient with an abnormal
appearing spleen. When performed, both splenic
and short-gastric vessels were preserved in 9 patients,
while in 5 only the short-gastric vessels were preserved
(Warshaw technique). Two patients in the Warshaw
group subsequently developed painful infarction of
the inferior splenic pole (40%) (managed conserva-
tively in both cases).
The total incidence of both major and minor
postoperative abdominal complications was 39%,
including 7 patients with pancreatic fistula (15%).
Early re-operation was performed in 1 patient on day
4 to control postoperative hemorrhage. There were no
in-hospital deaths (Table IV).
Two patients (one neuroendocrine tumor, the other
IPMN) developed new lesions near the pancreatic
stump during follow-up. Fearing recurrent disease,
these patients underwent re-operation at 7 and 11
postoperative months. In both cases, the lesions
turned out to be benign pseudocysts.
Discussion
Despite the first case of LDP being reported over a
decade ago, fewer than 300 cases have been added to
the world literature. The largest series to date is the
Multicentre European retrospective study, in which
82 LDPs, spread over 25 institutions, were reported
[4]. Only a handful of series deal with more than 10
cases (Table V), serving to highlight that the world-
wide experience with the technique still remains in its
infancy.
Comparative analysis of the data that are available,
however, does point to several advantages over open
distal pancreatectomy. Wound size and complications,
blood loss, length of hospital stay, time to return to
usual activities, and the rate of spleen preservation
rate favor the laparoscopic approach [4].
It is generally agreed that the lesions most suited for
LDP are benign lesions that are either symptomatic
(such as large serous cystadenomas) or carry potential
for malignant transformation (particularly mucinous
cystadenomas and IPMN). When located in the distal
pancreas, neuroendocrine tumors are often benign or
low-grade malignancy, and may also be appropriate
for LDP [57]. However, for frankly malignant
lesions, conventional open distal pancreatectomy
with splenectomy and celiac lymphadenectomy re-
mains the preferred approach by our institution.
Detecting the true nature of pancreatic lesions pre-
operatively is reliant on careful work-up that includes
fine-slice triple phase computed tomography (CT),
serum tumor markers, and selective use of endoscopic
ultrasound (EUS). The presence of metastases, nodal
involvement, loss of normal tissue planes, or frank
local invasion suggests malignancy. Fine-needle as-
piration, either percutaneously or during EUS for
cytology, mucin, lipase, and tumor markers, may be
potentially helpful, but remains controversial despite
recent evidence that the risk of tumor seeding may
have been overestimated previously [8].
Despite thorough preoperative work-up, the malig-
nant nature of a pancreatic lesion may not be revealed
until resection is attempted. Characteristics, including
infiltration into the Lessor Sac, may be more clearly
revealed operatively. Such operative findings prompted
conversion to open resection in 6 of 13 malignant
lesions resected in this series. However, there are
lesions appearing benign on both preoperative and
Table III. Method of stump closure vs fistula incidence (no differences reached statistical significance).
Method Additional measures No. Fistula
Stapled (65%) Alone 18 2 (11%)
Fibrin sealant 4 1 (25%) average 13%
Suture oversew 3 1 (33%)
Suture oversewn, fibrin sealant and omental patch 5 0
Sutured (35%) Alone 8 1 (13%) average 19%
Fibrin sealant 8 2 (25%)
}
}
Table IV. Perioperative complications (39%).
Complication Management No.
Pancreatic fistula
(15%)
Continued drainage 5
Percutaneous drainage 2
Bleeding Post-op transfusion 2
Laparotomy 1
Intra-abdominal
abscess
Percutaneous drainage 3
Wound infection Antibiotics and wound packing 2
Infarction inferior
pole spleen
Analgesia 2
Anastomotic leak
from synchronous
colonic resection
Percutaneous drainage and antibiotics 1
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operative assessment that turn out to be malignant, or
have a malignant focus, when examined by the
pathologist. We encountered this situation in seven
patients (15%), similar to the experience of other
researchers [9,10]. In our view, further management
of such patients (including consideration of re-
operation) is best determined on a case-by-case basis
within a multidisciplinary setting.
The incidence of pancreatic fistula in this series was
15% by our definition of persistent lipase-rich drai-
nage beyond 6 days or radiological drainage of lipase-
rich fluid collection. Rates of between 15% and 20%
are commonly reported after distal pancreatectomy,
regardless of whether performed laparoscopically or
open [4,918]. The risk appears inherently related to
distal pancreatomy rather than to the manner of
surgical access. Although relatively common, it is
rarely serious or life-threatening. In our series, no
patients required re-operation or developed serious
complications from pancreatic fistula, and all resolved
with simple drainage alone.
The risk of pancreatic fistula did not appear to
relate clearly to how the pancreatic stump was
managed, although we did notice a slight trend in
favor of stapled transection. Nearly identical findings
were reported in a much larger review by Knaebel et
al. which involved 1080 patients [19]. The use of
larger staples (4.8 mm open height) has been postu-
lated as a way of further reducing the risk [9].
Additional measures, such as applying fibrin sealant
to the pancreatic stump, did not appear to help either
after stapled or sutured closure in our series. Post-
operative somatostatin use has no proven benefit [4].
However, the consistency of the pancreas may play a
role, as fewer leaks seem to occur when affected by
chronic pancreatitis [20].
En bloc splenectomy is usually performed during
conventional open distal pancreatectomy. As the
important role of the spleen becomes better appre-
ciated, there is increasing enthusiasm for splenic
preservation whenever possible. Much higher rates
of splenic preservation, up to 85% in some series,
have been reported after LDP [4,8,9,11,13,15
17,21,22], perhaps indicating better preservation of
the spleen by the laparoscopic technique. Two meth-
ods have been described. The first involves preserva-
tion of both the splenic artery and vein by careful
dissection of the pancreatic tail away from these
vessels with ligation of side branches. The alternative
method, first described by Warshaw in 1988, main-
tains splenic perfusion solely by the short gastric
vessels. The main splenic vessels are divided twice:
first at the pancreatic neck, and second near the
splenic hilum, resulting in their en bloc excision with
the pancreas [3]. The choice of technique utilized in
our series was influenced by several considerations;
the ease of separating the pancreas from the adjacent
vessels, the degree of confidence in the lesion being
benign, and individual surgeon belief about the
relative merits of each method. In our experience
with Warshaw’s technique, two out of five patients
developed symptomatic infarction of their inferior
splenic poles. Other authors have reported more
serious problems, including splenic abscess or infarc-
tion of the entire spleen [4,10,12]. Despite the risk of
complications, the Warshaw technique may permit
preservation of the spleen when otherwise impossible.
When now using Warshaw’s technique, we take
particular care to preserve the lowermost short gastric
vessels when opening the gastrocolic ligament, and
preserve any extra hilar anastomotic branches when
dividing the main vessels near the splenic hilum.
Conclusions
LDP provides patients with the advantages of minimal
access surgery and is appropriate for benign and pre-
malignant lesions as well as neuroendocrine tumors.
Lesions exhibiting a malignant appearance on pre-
operative imaging or during initial laparoscopy should
still be managed by open resection until enough long-
term data accumulate. The incidence of pancreatic
fistula was 15% in this series and did not differ
significantly between stapled or oversewn stump
closure or with the application of fibrin sealant.
Spleen preservation is frequently possible, but care
needs to be taken to preserve blood supply to the
inferior pole when the Warshaw technique is used.
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